Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review
Manoj K. Mahapatra, Muthukumar Karuppasamy, Biswa Mohan Sahoo
Topics & Concepts
SemaglutideSteatohepatitisMedicineAgonistInsulin resistanceNeuroprotectionPharmacologyLiraglutideInternal medicineDiabetes mellitusType 2 diabetesFatty liverDiseaseEndocrinologyInsulinReceptorDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerDiabetes, Cardiovascular Risks, and Lipoproteins